---
created: 2025-04-13
updated: 2025-04-13T10:52
id: kCR(h/tEq@
specialty: pharmaco
specialty_id: 253
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::07-adp-receptor-inhibitors
  - "source/ak-step1-v11:": 
  - theme/nbme::29
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::adp-receptor-inhibitors
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::glycoprotein-iib/iiia-inhibitors
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::03-antiplatelet-agents
  - source/ak-step1-v11::^other::^highyield::1-highyield
type: flashcard
---

# Question
ADP receptor inhibitors (eg, clopidogrel) prevent expression of **GPIIb/IIIa** receptors on the platelet surface

---

# Answer
clopidogrel and prasugrel are pro-drugs